Cancer in children presents a formidable challenge, yet ongoing research holds promise for improved treatments and outcomes. Delving into the intricate molecular landscapes of pediatric cancers is pivotal for crafting tailored therapies with reduced long-term repercussions. Progress in genomics allows for pinpointing specific genetic aberrations fueling childhood cancers, opening avenues for personalized treatment strategies. Immunotherapy, leveraging the body's immune prowess to combat cancer cells, emerges as a beacon of hope in select pediatric malignancies. Furthermore, collaborative endeavors among researchers, clinicians, and advocacy groups are catalyzing advancements in pediatric oncology. Despite hurdles like funding constraints and limited access to experimental interventions, the relentless pursuit of groundbreaking therapies continues to steer the battle against childhood cancer.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States